Cytokinetics Retained Earnings (Accumulated Deficit) 2010-2024 | CYTK
Cytokinetics retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-2.552B, a 29.18% increase year-over-year.
- Cytokinetics retained earnings (accumulated deficit) for 2023 were $-2.112B, a 33.18% increase from 2022.
- Cytokinetics retained earnings (accumulated deficit) for 2022 were $-1.586B, a 31.33% increase from 2021.
- Cytokinetics retained earnings (accumulated deficit) for 2021 were $-1.208B, a 21.7% increase from 2020.